Cardiothoracic & vascular anesthesia

Restrictive versus liberal oxygenation in patients undergoing cardiopulmonary bypass-assisted heart surgery: a randomised controlled trial

Br J AnaesthPublished Randomised controlled trial

Primary resultResult — go to the resultHazard ratio 1.01 95% CI 0.8–1.3

Authors' conclusion

Among patients undergoing elective or urgent CPB-assisted coronary artery bypass grafting, aortic valve replacement, or both, no significant differences were observed in mortality, dialysis-dependent renal failure, stroke, or new-onset or worsening heart failure between a restrictive oxygenation strategy (Fio2 50%) and a liberal oxygenation strategy (Fio2 100%) during CPB and the subsequent weaning period.

Study context

Population
Adults undergoing cardiopulmonary bypass (CPB)-assisted coronary artery bypass grafting, aortic valve replacement, or both
Participants
1,389 adults
Comparison
Restrictive vs Liberal
  • Restrictiven = 695
  • Liberaln = 694reference
Primary endpoint
Time to composite of:
  • Death
  • Stroke
  • Renal failure requiring dialysis
  • New-onset or worsening HF
Follow-up
Median 5.9 yr (IQR 2.5-8.3)
Methodological detailssingle-centre, patient- and assessor-blinded
  • Single-centre
  • Patient- and assessor-blinded

Primary result

As reported in the abstract

Hazard ratio

1.01

95% CI 0.8–1.3

P = 0.92

Events by treatment group

Restrictive vs Liberal
HR 1.01 (95% CI 0.8–1.3); P = 0.92

Further findings

OutcomeRestrictiveLiberal
PaO2 during CPBmedian 19-23 kPamedian >60 kPa

Safety

No difference in adverse event rates between restrictive and liberal oxygen therapy

Original publication

Restrictive versus liberal oxygenation in patients undergoing cardiopulmonary bypass-assisted heart surgery: a randomised controlled trial. Br J Anaesth. Published 19 September 2025. doi:10.1016/j.bja.2025.08.005

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.